GLPG Awaits SAPHIRA Data, VTAE Vaults, CBLI Hits A Snag

It looks like the progress of regulatory review of Cleveland BioLabs Inc.'s (CBLI) pre-Emergency Use Authorization submission for Entolimod as a radiation countermeasure is going to be delayed.

from RTT - Biotech http://ift.tt/1MonJjm
via IFTTT